GHK-Cu raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-08-01. Anything still debated is marked as such rather than presented as settled.
The tripeptide was first isolated from a human plasma filtrate in 1973 during studies of tissue repair factors. Later work detected the free peptide and its copper complex in saliva, urine, and wound fluid, suggesting a natural role in tissue remodeling. Plasma concentrations reported in early literature decline with age, a pattern often cited in discussions of skin aging. Whether these endogenous levels are directly functional or largely incidental remains an open question. The peptide sequence is conserved across mammalian species.
Material described in research and cosmetic supply chains is typically a synthetic peptide supplied as a lyophilized powder. Purity is commonly reported through chromatographic separation, often at 95 percent or higher, while copper content is confirmed by separate elemental analysis. Batch variation in color and solubility can reflect residual counter-ions, moisture, or partial oxidation of the peptide. Because the complex is not a single regulatory entity, specifications differ between suppliers and are not standardized internationally.
GHK-Cu is a coordination complex formed between the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The peptide binds copper through its histidine imidazole nitrogen, its terminal amino group, and a deprotonated amide nitrogen, creating a stable chelate ring. The resulting complex carries a distinctive blue to blue-violet color, which arises from copper d-d electronic transitions. In the solid state it is usually handled as a powder, while in solution the complex can dissociate and re-form depending on pH and competing ligands. The name copper tripeptide-1 is widely used in ingredient listings.
GHK-Cu is a coordination complex formed between the tripeptide glycyl-L-histidyl-lysine and a copper(II) ion. The peptide sequence is conventionally written as Gly-His-Lys, abbreviated GHK. Copper binds through the imidazole nitrogen of histidine, the alpha-amino group, and a deprotonated amide nitrogen, producing a square-planar geometry. The complex carries a net positive charge near physiological pH and is intensely blue in aqueous solution. The metal-free peptide is often written simply as GHK, while the copper-bound form is written GHK-Cu.
The compound was first isolated from human plasma by the biochemist Loren Pickart in 1973. Early work identified it as a factor that altered the behavior of cultured liver cells, and later studies linked it to connective tissue and wound-related processes. Reported plasma concentrations fall markedly between roughly age twenty and age sixty, a pattern that generated interest in copper peptide biology. Whether that decline has functional consequences remains an open question, because differences observed across age groups do not by themselves establish causation. Research interest later expanded into cosmetic and tissue-culture settings.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C14H24N6O4 | Free tripeptide, without copper |
| Molecular weight | About 340 g/mol | Peptide portion only |
| Appearance | Blue to violet powder | Color from copper coordination |
| Solubility | Soluble in water | pH influences dissolution |
| Common synonyms | Copper tripeptide-1, Cu-GHK | Seen on ingredient labels |
The peptide portion consists of three amino acids: glycine, histidine and lysine. Copper(II) coordinates through the imidazole nitrogen of histidine, the alpha-amino group of glycine and a deprotonated amide nitrogen of the backbone, producing a roughly square-planar geometry. This arrangement gives the complex its characteristic blue-to-violet colour and helps it resist dissociation in water. Reported stability constants are high, although values differ between studies because of differences in ionic strength and measurement method.
The International Nomenclature of Cosmetic Ingredients lists the substance as copper tripeptide-1, the name that appears on most topical product labels. Related designations include copper peptide and GHK-Cu, and the hyphenated form is common in research literature. In cosmetics the material is regulated as an ingredient rather than as a drug, so products may reach the market without evidence of the effects claimed for them. Whether those effects are clinically meaningful is an open question, since most supportive data come from laboratory work and small trials.
GHK-Cu is the copper complex of the tripeptide glycyl-L-histidyl-L-lysine, a short sequence found naturally in human plasma, saliva and urine. Loren Pickart reported the isolation of the free peptide in 1973 while studying factors that influenced the growth of aged liver cells in culture. The peptide was later shown to bind copper(II) with high affinity, and the metal-bound form became the focus of most subsequent research. Its concentration in circulation declines markedly with age, a pattern that is well documented, though the physiological consequences of that decline remain debated.
Published studies describe the complex in several research contexts, including collagen synthesis, antioxidant behaviour, and wound repair models. Much of this work is conducted in cultured cells or in small animal systems, and the findings are frequently cited in reviews of copper peptides. Direct clinical evidence in humans is comparatively limited, and reported outcomes vary with formulation and study design. Whether free chain or metal-bound form was used is not always stated, a point that complicates comparison between reports.
GHK-Cu is a coordination complex formed between the peptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The unbound chain, abbreviated GHK, consists of three amino acids and occurs naturally in human plasma, saliva, and urine. Binding of the metal is mediated mainly by the imidazole nitrogen of the histidine residue together with backbone amides, producing a stable chelate. Ingredient nomenclature often lists the same substance as copper tripeptide-1. Its charge and solubility behaviour differ from those of the metal-free chain.
The copper-binding activity of this sequence was described in the 1970s during studies of liver tissue and plasma factors. Early work identified the peptide as a component that influenced copper uptake by cells and that appeared in wound fluid. Later investigations examined its presence across species, reporting the same chain in human and animal samples. A decline in measured concentration with age became a recurring observation, although the underlying causes remain incompletely characterised.
Endogenous GHK occurs in blood plasma, saliva, and urine, and reported plasma concentrations decline with age in several studies. Researchers have proposed that the peptide acts as a copper carrier that delivers the metal to cells and to sites of injury. That transport role is a hypothesis supported by binding measurements and tissue-distribution data rather than a settled mechanism, and the peptide is generally described as a minor contributor to total plasma copper transport. Values reported in wound fluid and certain tissue extracts are higher than in circulating plasma.
The sequence carries three residues in the order glycine, histidine, lysine, which places a small, flexible chain around a single metal centre. Compared with larger copper-binding proteins, the complex is compact and its coordination chemistry can be reproduced with synthetic peptide in a laboratory. Published structural work agrees on the nitrogen donor set but differs in the exact geometry assigned under some conditions, so the arrangement is best treated as well characterised in outline rather than fixed in every detail.
Discovery of GHK is generally attributed to work in the 1970s that isolated a plasma factor influencing liver cell behavior. Subsequent studies identified the copper-binding tripeptide and its ability to chelate copper with high affinity. Early reports linked the complex to wound healing and tissue remodeling in animal models. The free peptide and the copper-bound form have different properties, so the two are distinguished in the literature. Whether endogenous GHK-Cu serves a single primary physiological role remains an open question.
The molecular weight and charge of GHK-Cu depend on the pH and the number of coordinated ligands. At neutral pH, the peptide typically binds one copper ion, but ternary complexes with other biomolecules can form. Spectroscopic methods such as electron paramagnetic resonance and circular dichroism are used to study the coordination environment. Reports on the exact geometry vary because the complex is dynamic in solution. Researchers often use synthetic GHK-Cu rather than extracted material to control stoichiometry and purity.
GHK-Cu is a coordination complex formed from the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The peptide binds copper through its histidine imidazole nitrogen, the terminal amino group, and the deprotonated amide nitrogen. This arrangement creates a square-planar or distorted geometry around the metal center, depending on pH and the presence of competing ligands. The complex occurs naturally in human plasma, saliva, and urine at low concentrations, and its sequence is conserved across many vertebrate species.
Doxycycline was patented in 1957 and came into commercial use in 1967. It is on the World Health Organization's List of Essential Medicines. Doxycycline is available as a generic medicine. In 2023, it was the 77th most commonly prescribed medication in the United States, with more than 8 million prescriptions.
In sports where physical strength is favored, athletes have used anabolic steroids, known for their ability to increase physical strength and muscle mass. The drugs mimic the effect of testosterone and dihydrotestosterone in the body. They were developed after Eastern Bloc countries demonstrated success in weightlifting during the 1940s. At the time they were using testosterone, which carried with it negative side effects, and anabolic steroids were developed as a solution. The drugs have been used across a wide range of sports from football and basketball to weightlifting and track and field. While not as life-threatening as the drugs used in endurance sports, anabolic steroids have negative side effects, including:
=== The supersensitivity theory === The supersensitivity theory proposes that certain individuals who have severe mental illness also have biological and psychological vulnerabilities, caused by genetic and early environmental life events. These interact with stressful life events and can result in either a psychiatric disorder or trigger a relapse into an existing illness. The theory states that although anti-psychotic medication can reduce the vulnerability, substance use may increase it, causing the individual to be more likely to experience negative consequences from using relatively small amounts of substances. These individuals, therefore, are "supersensitive" to the effects of certain substances, and individuals with psychotic illness such as schizophrenia may be less capable of sustaining moderate substance use over time without experiencing negative symptoms. Although there are limitations in the research studies conducted in this area, namely that most have focused primarily on schizophrenia, this theory provides an explanation of why relatively low levels of substance misuse often result in negative consequences for individuals with severe mental illness.
Sources: en.wikipedia.org
16 May – Greggs reaches a deal with Westminster City Council to allow it to sell food and hot drinks at its Leicester Square outlet until 2.00am on some nights. The council had objected to a previous plan for 24-hour opening amid concerns it would attract antisocial behaviour, with the agreement reached as a court case was about to commence. 17 May – The £2 cap on bus fares in England is extended until the end of October; a £2.50 cap will then be in place until December 2024. 18 May – Two teenage cousins are sentenced to life imprisonment for the murder of Khayri Mclean, who was stabbed in Huddersfield, West Yorkshire in 2022 as he walked home from school. 22 May – After the latest round of talks with the government end without resolution, the British Medical Association announces that junior doctors will stage another 72-hour strike, scheduled to begin on 14 June. 23 May – Samantha Lee, a former Metropolitan Police constable who failed to properly investigate two counts of indecent exposure committed by Wayne Couzens, is found guilty of gross misconduct following a hearing. David Boyd is sentenced to life imprisonment with a minimum term of 29 years for the 1992 murder of Nikki Allan. 25 May – The UK Health Security Agency urges people at risk of contracting the Mpox virus to get vaccinated after 10 new cases were discovered in London between 30 April and 25 May.
Pratt (JP.1), it was entirely due to Collip's expertise that a far less toxic extract from that of Banting and Best's had been produced in just five weeks (p.288). Moreover, he was certain that, without Collip, the Toronto team would never have had an extract that was safe enough to administer to any human being. Also, according to Pratt (pp.286-288), the (pre-Collip) efforts of Banting and Best had been no improvement upon the work of George Ludwig Zuelzer fifteen years earlier: who, despite having been "on the right track" (in relation to recognizing the potential efficacy of a pancreatic extract in the treatment of diabetes mellitus) and, "even with the able assistance of the staff of the Physiological Institute of the University of Berlin as well as that of the trained chemists of the Schering Company over a period of four years [viz., prior to Zuelzer's 1907 publication], had been unable to lessen its toxicity sufficiently to have it employed clinically" (pp.286-288). By 22 February 1922, the Toronto team were reporting that "the effects observed in depancreatized animals have been paralleled in man", that the condition of seven patients had been "favourably influenced" by the daily injection of the extract, and that "the patients themselves report[ed] a subjective subjective sense of well being and increased vigor for a period following the [extract's] administration".
Richmond-Bridgeport MLA Teresa Wat claims Findlay made “unfounded accusations about me, including remarks that called my allegiance to Canada into question,” stating she "cannot continue to sit in a caucus led by someone who has questioned my loyalty without evidence and, when given the opportunity to correct the record, has failed to do so.” Courtenay-Comox MLA Brennan Day issued a statement criticizing Findlay's leadership, writing "I have lost confidence in the judgement, conduct, and ethical standards of her leadership and those she has chosen to surround herself with." Abbotsford South MLA Bruce Banman, the first MLA to cross the floor and join John Rustad as a Conservative, wrote "person after person has informed me they have decided that our new leader is unelectable," instead he is "joining an ever increasing number of MLAs to sit as an independent MLA in the BC Legislature". Banman also wrote he "would encourage my fellow MLAs regardless of political affiliation to join me." Boundary-Similkameen MLA Donegal Wilson cited Findlay's hiring of "Alberta separatist[s]" as the reason for her resignation, along with Findlay's inability to "bring Conservatives back together.” MLAs Ian Paton of Delta-South, Peter Milobar of Kamloops Centre, Rosalyn Bird of Prince George-Valemount, Áʼa꞉líya Warbus of Chilliwack-Cultus Lake, Scott McInnes of Columbia River-Revelstoke, and Linda Hepner of Surrey-Serpentine River also announced their resignation from the party. In September 2026, Findlay removed three MLAs from the Conservative caucus for questioning her leadership.
Disease-modifying antirheumatic drugs (DMARDs), such as hydroxychloroquine and methotrexate, may be used to try to slow the progression of disease. Biological DMARDs may be used when the disease does not respond to other treatments. However, they may have a greater rate of adverse effects. Surgery to repair, replace, or fuse joints may help in certain situations. Rheumatoid arthritis affects about 17.6 million people globally, as of 2020. This is 0.5–1% of adults in the developed world with between 5 and 50 per 100,000 people newly developing the condition each year. Onset is most frequent during middle age and women are affected 2.5 times more than men. It resulted in 38,300 deaths in 2020, up from 28,000 deaths in 1990. The first recognized description of RA was made in 1800 by Dr. Augustin Jacob Landré-Beauvais (1772–1840) of Paris. The term rheumatoid arthritis is based on the Greek words for watery and inflamed joints (from Ancient Greek ῥεῦμα (rheûma) 'flowing current', with arthritis derived from arthr- (meaning 'joint') and -itis (meaning 'inflammation')).
Sources: en.wikipedia.org
Entrepreneur of the Year, Recipient 1981 (Awarded by the Research Directors' Association of Chicago) Entrepreneur of the Year, Recipient 1983 (Awarded by Stanford Business School Alumni Association, Peninsula Chapter) Golden Plate Award of the American Academy of Achievement, Recipient 1986 Distinguished Entrepreneur of the Year, Recipient 1993 (Awarded by Babson College) Exemplary Leadership in Management Award, Recipient 1997 (Anderson School of Business) National Medal of Technology, Recipient 1999 Biotechnology Heritage Medal, Recipient 2000 (Posthumously Awarded by the Biotechnology Industry Organization and the Chemical Heritage Foundation) Royal Swedish Academy of Engineering Sciences, Appointed Member
A crystal structure of the serotonin 5-HT2B receptor bound to LSD reveals an extracellular loop that forms a "lid" over the diethylamide end of the binding cavity and "traps" LSD in the binding pocket, which explains the slow rate of LSD unbinding from serotonin receptors. The related lysergamide lysergic acid amide (LSA) that lacks the diethylamide moiety is far less potent in comparison. Moreover, a specific residue in the binding pocket is partially responsible for the prolonged action of LSD, and this residue is found in the human protein but not in the receptors of rodents. LSD is an extraordinarily potent psychoactive drug and is among the most potent psychedelics known in humans. The very high potency of LSD in producing psychedelic-like effects is also the case in animals, including rodents and monkeys. It is unclear why LSD is so potent. The affinity and activational potency of LSD at the human serotonin 5-HT2A receptor in vitro is unremarkable compared to other psychedelics such as DOI and DOB. There is no evidence for its greater potency being related to pharmacokinetics or metabolism. It appears that the N,N-diethylamide moiety of LSD fits into a sterically constrained region of the serotonin 5-HT2A receptor that specifically accommodates this moiety. LSD, like other psychedelics, has been found to increase the expression of genes related to synaptic plasticity and hence to have psychoplastogenic effects. This appears to be mediated by serotonin 5-HT2A receptor agonism.
== Safety == In vivo dermal sensitization studies according to OECD 429 confirmed CMDT is a strong skin sensitizer, showing a response at 0.03 wt% in the local lymph node assay (LLNA) placing it in Globally Harmonized System of Classification and Labelling of Chemicals (GHS) Dermal Sensitization Category 1A. These studies confirm that DMTMM is a less sensitizing alternative to CDMT, as suggested by anecdotal observations in the literature.
== Function == The MMPs play an important role in tissue remodeling associated with various physiological or pathological processes such as morphogenesis, angiogenesis, tissue repair, cirrhosis, arthritis, and metastasis. MMP-2 and MMP-9 are thought to be important in metastasis. MMP-1 is thought to be important in rheumatoid arthritis and osteoarthritis. Recent data suggests an active role of MMPs in the pathogenesis of aortic aneurysms; excess MMPs degrade the structural proteins of the aortic wall. Dysregulation of the balance between MMPs and TIMPs is also a characteristic of acute and chronic cardiovascular diseases.
However, Smithwick et al.'s study noted that, after further preparation, this irregular surface was simply a layer of sediment with a different color than the rest of the slab. The 'frill' or 'halo' of collagen identified by Feduccia was also determined to be misidentified sediment surrounding one of the specimens. Smithwick et al.'s study concluded by stating that the integument preserved on Sinosauropteryx closely resembled that of birds preserved in the same formation. Purported features of collagen fibers were in fact misidentified shadows formed by scratches or irregular sediment, a misidentification perpetuated by the low quality of early Sinosauropteryx photographs.
Sources: en.wikipedia.org
It is a complex of the tripeptide glycyl-L-histidyl-L-lysine with a copper(II) ion. The peptide coordinates the metal through its histidine, amino terminus, and an amide nitrogen. It is often listed simply as copper tripeptide-1.
The peptide and its copper form have been detected in human plasma, saliva, and urine. Early reports describe levels that fall with age. The functional meaning of these pools is still debated.
Chromatographic separation gives peptide purity, often reported as a percentage. Copper content is checked by a separate elemental method. Moisture and counter-ions may be reported as well.
It is the copper(II) complex of the tripeptide glycyl-L-histidyl-lysine, a sequence of three amino acids. The copper ion is held by the histidine imidazole, the terminal amino group, and an amide nitrogen. The bound form is distinct from the free peptide in charge, color, and stability.